WATERS CORPORATION Reports Earnings Results for Q2 FY2023

August 8, 2023

🌥️Earnings Overview

On August 2 2023, WATERS CORPORATION ($NYSE:WAT) released their financial results for the second quarter of FY2023, which concluded on June 30 2023. The total revenue for the period was USD 740.6 million – a 3.7% increase from the same quarter of the prior year. Unfortunately, net income for the quarter decreased 8.7% year-on-year to USD 150.6 million.

Stock Price

On Wednesday, WATERS CORPORATION announced its earnings results for the second quarter of its fiscal year 2023. The stock opened at $282.0 and closed at $291.8, a rise of 6.3% from its last closing price of 274.4. The company is optimistic that its financial results will continue to improve as the year progresses and is confident in its ability to generate strong returns for its shareholders in the future. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Waters Corporation. More…

    Total Revenues Net Income Net Margin
    2.99k 674.54 22.5%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Waters Corporation. More…

    Operations Investing Financing
    571.67 -1.47k 799.51
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Waters Corporation. More…

    Total Assets Total Liabilities Book Value Per Share
    4.55k 3.78k 13.06
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Waters Corporation are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    9.5% 10.4% 29.0%
    FCF Margin ROE ROA
    12.9% 79.2% 11.9%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we have conducted an analysis of WATERS CORPORATION‘s fundamentals. After careful consideration, we have determined that this company has a medium risk rating, in terms of both financial and business aspects. We have identified two risk warnings in WATERS CORPORATION’s balance sheet and non-financial indices. If you’re interested in learning more, please head over to our website at goodwhale.com to check out the full report. Here, you can find a complete breakdown of our findings and a detailed assessment of WATERS CORPORATION’s financial health. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis

  • Peers

    Waters Corporation is an American analytical instrument manufacturing company that specializes in liquid chromatography, mass spectrometry, and thermal analysis instruments. It has annual sales of over $2 billion and employs more than 6,000 people worldwide. Its products are used in the life sciences, pharmaceutical, and chemical industries. Waters Corporation’s main competitors are IQVIA Holdings Inc, Agilent Technologies Inc, Vijaya Diagnostic Centre Ltd.

    – IQVIA Holdings Inc ($NYSE:IQV)

    The company’s market cap as of 2022 was 39.27B and its ROE was 21.52%. The company is a global provider of information, innovative technology solutions, and real-world insights that help customers improve their well-being. The company offers a broad range of products and services that enable customers to manage their health and wellbeing.

    – Agilent Technologies Inc ($NYSE:A)

    Agilent Technologies, Inc. is a provider of life sciences, diagnostics, and applied chemical markets solutions. It operates through three segments: Life Sciences and Applied Markets Group, Diagnostics and Genomics Group, and Agilent CrossLab Group. The Life Sciences and Applied Markets Group segment offers application solutions that include chromatography, mass spectrometry, chemical analysis, and cellular analysis. The Diagnostics and Genomics Group segment provides in vitro diagnostic products and services. The Agilent CrossLab Group segment offers a range of services and consumables. Agilent Technologies was founded in 1999 and is headquartered in Santa Clara, California.

    – Vijaya Diagnostic Centre Ltd ($BSE:543350)

    Vijaya Diagnostic Centre Ltd is a leading diagnostic centre in India with a market cap of 46.61B as of 2022. The company has a return on equity of 17.7%. The company offers a wide range of diagnostic services including X-rays, ultrasounds, MRI, and CT scans. The company also has a wide network of centres across India.


    WATERS CORPORATION announced their second quarter of FY2023 earnings results on August 2, 2023, showing total revenue of USD 740.6 million, up 3.7% from the same period last year, and net income of USD 150.6 million, down 8.7%. The stock price responded positively to the news, moving up the same day. Investing in WATERS CORPORATION is attractive for those looking for mid-term returns, as the company has demonstrated consistent and steady growth in revenue and profits over the past few quarters.

    The company’s financial position is strong due to its low debt and high cash levels, and it is well-positioned to take advantage of potential future opportunities. As such, WATERS CORPORATION may be an attractive investment for those seeking capital appreciation or income generation.

    Recent Posts

    Leave a Comment